Diabetes

Novo Nordisk presented data for 2 mg dose of Ozempic at the 81st Annual Scientific Sessions of the American Diabetes Association.

This study was among the first to display the adverse relationship in younger adults, according to the letter.

The DARE-19 clinical trial explores the use of SGLT2 inhibitors for patients with hypertension, cardiovascular disease, heart failure, type 2 diabetes, or chronic kidney disease, and COVID-19.

Study presented at the American Diabetes Association (ADA) 81st Scientific Sessions shows meaningful outcomes for people with diabetes who use the FreeStyle Libre system.

Data show diabetes patients not taking medication experienced longer hospitalization and recovery from the coronavirus.

Too much bile acids can lead to damage in the cell membranes and can cause cell death and inflammation.

Initial data show that children presented with higher acuity in 2020 compared to the previous year.

Studies show that an increased life expectancy is attributable to growth in gross domestic product, increases in the average years of school, and other social factors.

Improvements in glycemic control were seen as early as 3 months after program implementation and were sustained up to a year with continued program engagement.

The objective of the study was to determine the impact of telemedicine consultations in the context of the COVID-19 pandemic on the glycemic control of patients at an endocrinology clinic.

Researchers observed improvements in total cholesterol, low-density lipoprotein, triglycerides, and serum gamma glutamyl transferase among patients both with and without diabetes.

Individuals with diabetes, and other related underlying health conditions, are being hospitalized 6 times more often and are 12 times more likely to die of COVID-19 than those without diabetes.

The researchers noted that during high-risk pregnancies, special monitoring and care throughout the pregnancy is mandatory.

Researchers noted decreases in control of blood pressure as well as non¬–high-density lipoprotein cholesterol, both of which are risk factors for diabetes.

The researchers found that the effect of fatigue from sleep disruption increased among patients with diabetes.

Continuous glucose monitors were associated with a decline in levels of HbA1c as well as reduced emergency department visits and hospitalizations for hypoglycemia.

After identifying 3 novel checkpoints involved in immunosuppression and autoimmune diseases, investigators developed recombinant proteins that could be used in this patient population.

Investigators from Monash University determined the prevalence of undiagnosed type 2 diabetes utilizing machine learning to analyze modifiable markers not included in screening guidelines.

By encouraging patients to find activities they enjoy and celebrating small improvements, health care professionals can help patients improve mild to moderate hypertension and elevated cholesterol.

Semaglutide (Wegovy) injection is indicated for use with a reduced calorie meal plan and increased physical activity to help adults with obesity or overweight, who also have weight-related medical problems, lose weight and maintain weight loss.

Semaglutide (Ozempic) is a glucagon-like peptide 1 receptor agonist, approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Researchers at the National Institutes of Health (NIH) found that pregnant women only made slight changes to their diet after a gestational diabetes diagnosis.

Researchers found an association between fruit intake and markers of insulin sensitivity, which meant that people who consumed more fruit had to produce less insulin to lower their blood glucose levels.

Launched in 2020, a diabetes pilot program resulted in a significant improvement in patient outcomes for those enrolled.

Study examines whether implementing an oral care protocol for general practitioners can improve patient-centered outcomes for individuals with type 2 diabetes.